Patient Square Capital LP Roivant Sciences Ltd. Transaction History
Patient Square Capital LP
- $277 Billion
- Q2 2025
A detailed history of Patient Square Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Patient Square Capital LP holds 12,480,000 shares of ROIV stock, worth $144 Million. This represents 50.71% of its overall portfolio holdings.
Number of Shares
12,480,000
Previous 12,480,000
-0.0%
Holding current value
$144 Million
Previous $126 Billion
11.69%
% of portfolio
50.71%
Previous 52.09%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
361Shares Held
456MCall Options Held
8.34MPut Options Held
720K-
Sb Investment Advisers (Uk) LTD London, X060MShares$694 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$517 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$396 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...